Previous 10 | Next 10 |
Cellectar Biosciences (NASDAQ: CLRB ) initiated with Buy rating and $6 (180% upside) price target at Brookline Capital. Shares up 8% premarket. More news on: Cellectar Biosciences, Inc., Heat Biologics, Inc., Progenics Pharmaceuticals, Inc., Healthcare stocks news, Stocks on th...
NEW YORK, July 29, 2019 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Genomic Health, Inc. (NASDAQ: GHDX) to Exact Sciences Corp. is fair to Genomic Health shareholders. On behalf of Genomic Health shareholders, Halper Sad...
Exact Sciences (NASDAQ: EXAS ) and Genomic Health (NASDAQ: GHDX ) have agreed to merge in a cash-and-stock transaction valued at $2.8B ($72/GHDX common share). The deal should close by year-end. More news on: Exact Sciences Corporation, Genomic Health, Inc., Healthcare stocks news, Stock...
Genomic Health (NASDAQ: GHDX ): Q2 GAAP EPS of $0.42 beats by $0.07 . More news on: Genomic Health, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Stitcher and Spotify (click the highlighted links). Negotiators for the U.S. and China are facing off in Shanghai this week in another attempt to piece ...
REDWOOD CITY, Calif. , July 29, 2019 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today reported financial results and business progress for the quarter ended June 30 , 2019. The company's earnings call and webcast previously scheduled for Thursday, August 1 ...
MADISON, Wis. and REDWOOD CITY, Calif. , July 29, 2019 /PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS) and Genomic Health, Inc. (NASDAQ: GHDX) today announced that the companies have entered into a definitive agreement under which Exact Sciences will combine with Genomic...
Bloomberg reports that Exact Sciences (NASDAQ: EXAS ) is in advanced talks to acquire Genomic Health (NASDAQ: GHDX ) for $2.8B. A deal could be announced as early as next week. More news on: Exact Sciences Corporation, Genomic Health, Inc., Healthcare stocks news, Merger & acquisitio...
REDWOOD CITY, Calif. , July 25, 2019 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today announced that the company will host a conference call and webcast on Thursday, August 1 at 4:30 p.m. Eastern Time to discuss its second quarter 2019 financial results. T...
Gainers: DelMar Pharmaceuticals (NASDAQ: DMPI ) +39%. SigmaTron International (NASDAQ: SGMA ) +22% . Nuvectra Corporation (NASDAQ: NVTR ) +20% . Teradyne (NASDAQ: TER ) +18% . Manhattan Associates (NASDAQ: MANH ) +18% . Snap (NYSE: SNAP ) +16% . Acasti Pharma (NASDAQ: ACS...
News, Short Squeeze, Breakout and More Instantly...
Genomic Health Inc. Company Name:
GHDX Stock Symbol:
NASDAQ Market:
Broadly, genetics is the study of genes, their variations and hereditary characteristics. As Live Science describes it , genetics involves looking at how traits are passed on through generations. So what is genetics investing? When it comes to genetics investing, companies in this niche li...
Combined company joins two leading brands in cancer diagnostics, Cologuard® and Oncotype DX®, providing a strong platform for continued growth MADISON, Wisconsin , Nov. 8, 2019 /PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS) today announced that it has completed its...
REDWOOD CITY, Calif. , Nov. 7, 2019 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) announced that its stockholders voted to approve the company's proposed combination with Exact Sciences Corp (NASDAQ: EXAS) at a special meeting held earlier today. As previously announced...